Navigation Links
John Theurer Cancer Center offers breakthrough radiation measurement technology
Date:5/17/2010

HACKENSACK, N.J. (May 17, 2010) John Theurer Cancer Center at Hackensack University Medical Center announced today that it is one of two cancer centers in the tri-state area currently implanting a wireless radiation sensor, known as DVS (Dose Verification System). John Theurer Cancer Center radiation oncologists can now receive data immediately post- treatment on the precise amount of radiation being delivered to tumors and surrounding tissue for prostate cancer treatments.

"Traditional radiation therapies rely on knowing the exact location of the tumor, but provide no guidance on quantifying the actual dose being delivered to the tumor," said Glen Gejerman, M.D., Co-Chief, Urologic Oncology and Director, Radiation Oncology, John Theurer Cancer Center. "With this implantable device, we can now offer critical same day radiation dose adjustments."

The DVS sensorsjust 2.1mm in diameter and 20mm longare implanted during a minimally invasive procedure and gather data on the precise amount of radiation being delivered to the tumor. Wireless technology transmits the information to a hand-held monitor and the amount of radiation absorbed is read at the end of each of the daily treatments, enabling doctors to verify that the patient is receiving the prescribed dose.

Deviations in dose delivered to the tumor, or radiation accidentally administered to normal tissue, can have a profound impact on long-term survival rates and quality of life for patients treated with radiation therapy. Accurate delivery of the appropriate dose of radiation is critical to tumor control and cure rate. A long-term clinical study of nearly 230 prostate cancer patients demonstrated statistical significance between dose and benefit, highlighting the importance of measuring the amount of dose delivered. 1

This is part of John Theurer Cancer Center's ongoing dedication to improving radiation oncology safety and precision through research and adopting the latest technological advancements. John Theurer Cancer Center is the most experienced cancer center in the tri-state area with this implantable device. Dr. Gejerman and his colleagues at John Theurer Cancer Center plan to continue studying the DVS technology to determine the optimal number of sensors to implant and the most favorable locations in the body to implant them. In doing so, they plan to streamline the process of radiation delivery and make it even more precise.

"John Theurer Cancer Center is committed to providing extraordinary care by offering patients innovative technologies to help us improve patient outcomes and to tackle the most complicated cases," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chairman and Executive Administrative Director, John Theurer Cancer Center. "We are excited to offer an unprecedented level of precision to physicians and added peace of mind to our prostate cancer patients."


'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
2. Researchers at the John Theurer Cancer Center Present Cutting-Edge Research Results at this Years American Society of Hematology Annual Meeting
3. Motorcycle Cancer Risk and ELF EMF Radiation Invasion of Gastrointestinal Melatonin
4. Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists
5. 5th Annual Brittiana 'Smile For Life' 5k run/walk - Helping Children Survive Cancer One Smile at a Time
6. Relax for Hope May 23 - a Spa Day Fundraiser for the American Cancer Soiety's Relay for Life in Lincoln City, Oregon.
7. CIGNA and Cancer Treatment Centers of America Reach New Agreement
8. Can Celebrex prevent cancer-causing colon polyps?
9. Study identifies 1 of the mechanisms behind breast cancer metastasis
10. NYU College of Dentistry, Penn State develop new model for investigating tobacco/oral cancer link
11. New hope for better treatment for a rising cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... edition of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic ... health while maintaining fulfilling lives. “We are prolonging life 6 years in the ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering local frontline ... field of pain management. , The demand for supplemental training related to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the ... its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition ... has been available in several ShopRite and FoodTown stores in NJ and received rave ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in ... fits into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started ... how the details line up exactly with Bible Prophecy – a protected way for ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016   CytoSorbents Corporation (NASDAQ: ... its European Union approved CytoSorb ® cytokine adsorber ... patients worldwide, announced that Dr. Phillip Chan , ... Annual LD Micro Main Event investor conference held ... the Luxe Sunset Boulevard Hotel in Los ...
(Date:12/2/2016)...  Today, Simpson Healthcare Executives, a global leader in ... as winners of multiple awards at the 2016 MarCom ... PLATINUM level, Blue Zones Menu at the GOLD Level, ... and our proprietary 3ConneX Platform at the HONORABLE MENTION ... are excited to showcase our new Platinum and Gold ...
(Date:12/2/2016)... 2016 The iShares Nasdaq Biotechnology Exchange-Traded ... Trump,s victory early in November. Less political risk has ... now predicting an uptick in M&A activities. Today, Stock-Callers.com ... how they have fared at the last close: Celldex ... Inc. (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. ...
Breaking Medicine Technology: